Gene transfer in the lung using recombinant adeno-associated virus
UMass Chan Affiliations
Department of Microbiology and Physiological SystemsDepartment of Pediatrics
Gene Therapy Center
Document Type
Book ChapterPublication Date
2012-08-01Keywords
DependovirusGenetic Vectors
Gene Therapy
Transgenes
Gene Transfer Techniques
Lung
Allergy and Immunology
Genetics and Genomics
Medical Genetics
Pediatrics
Respiratory Tract Diseases
Metadata
Show full item recordAbstract
Adeno-associated virus (AAV) is a small replication-deficient DNA virus belonging to the Parvovirinae family. It has a single-stranded ∼4.7-kb genome. Recombinant AAV (rAAV) is created by replacing the viral rep and cap genes with the transgene of interest along with promoter and polyadenylation sequences. The short viral inverted terminal repeats must remain intact for replication and packaging in production, as well as vector genome processing and persistence in the transduction process. The AAV capsid (serotype) determines the tissue tropism of the rAAV vector. In this unit we will discuss serotype selection for lung targeting along with the factors effecting efficient delivery of rAAV vectors to the murine lung. Detailed procedures for lung delivery (intranasal, orotracheal, and surgical tracheal injection), sample collection, and post-mortem tissue processing will be described. Curr. Protoc. Microbiol. 26:14D.2.1-14D.2.17. © 2012 by John Wiley & Sons, Inc.Source
Curr Protoc Microbiol. 2012 Aug;Chapter 14:Unit14D.2. DOI: 10.1002/9780471729259.mc14d02s26
DOI
10.1002/9780471729259.mc14d02s26Permanent Link to this Item
http://hdl.handle.net/20.500.14038/43860PubMed ID
22875566Related Resources
Link to article in PubMedae974a485f413a2113503eed53cd6c53
10.1002/9780471729259.mc14d02s26